Allkem Scheme Meeting - Chairman's address and presentation - Seite 2

Chairman’s Address

[Slide 1]

Good morning to everyone here in Perth and to those joining us online. My name is Peter Coleman, the Chairman of Allkem Limited, and it is my pleasure to chair today’s Scheme Meeting.

Firstly, as a matter of housekeeping, should the building fire alarm sound or you are advised that there is an emergency in the building, there are 2 fire exits located at the back of the room and one fire exit located at the front of the room. The Crown staff will direct you to the nearest safety exit and designated assembly area.

We begin by acknowledging the traditional custodians of the land we are meeting on today, the Whadjuk Nyoongar people. We pay our respects to their Elders past and present. We extend that respect to any Aboriginal and Torres Strait Islander peoples here today and to those joining us online.

Your Allkem Directors joining us online today include:

• Our Managing Director – Martín Perez de Solay;
• Non-Executive Director – Richard Seville;
• Non-Executive Director – Leanne Heywood;
• Non-Executive Director – Alan Fitzpatrick;
• Non-Executive Director – Florencia Heredia;
• Non-Executive Director – John Turner; and
• Non-Executive Director – Fernando Oris de Roa.
  

On behalf of my fellow Directors, welcome to Allkem’s Scheme Meeting.

[Slide 2]

The purpose of this meeting is for Allkem shareholders to vote on the scheme of arrangement in relation to the proposed merger of equals with Livent Corporation.

The proposed merger with Livent will combine two global lithium companies and bring together their highly complementary range of assets, growth projects and operating skills across extraction and processing under a vertically integrated business model, with the scale and expertise to meet the rapidly growing demand for lithium chemical products.

The merged entity will have a significant portfolio of lithium assets diversified across key geographies, products and customers. Cost synergies and capital expenditure savings, in addition to other anticipated commercial synergies, are expected to be realised from the opportunity to co-develop and de-risk future expansion projects and operations.

Your Allkem Directors believe that the Transaction is logical and highly compelling, with strong strategic rationale and significant synergies that are expected to drive value for Allkem Shareholders.

The Independent Expert’s Report concluded that the scheme is in the best interest of shareholders, in the absence of a superior proposal, and that remains the Independent Expert’s conclusion today.